QIAcuity digital PCR now offers ability for simultaneous detection of up to 12 targets from one biological sample, a more than two-fold increase from prior capability for up to five targets No ...
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced financial results for the fourth quarter and ...
Reports Q4 revenue $521M, consensus $518.54M. The company said, “Our solid sales growth in the second half of 2024 mirrors our plans for ...
Hosted on MSN1mon
QIAGEN introduces new custom tools for microbial analysisQIAGEN has introduced two tools designed to advance microbial analysis by allowing researchers to customise their assays and panels. These tools are compatible with QIAcuity digital polymerase ...
Bernard emphasized strong performances in the QIAstat Diagnostics and QuantiFERON portfolios, with QIAstat achieving 25% CER growth in Q4 and over 660 new system placements in 2024. QuantiFERON grew ...
Qiagen, a Netherlands-based leading global provider of Sample to Insight solutions, announced a significant increase in the powerful capabilities of its QIAcuity Digital PCR (dPCR) system with a more ...
Net sales of $525 million CER ahead of outlook for at least $520 million CER and adjusted diluted EPS of $0.61 CER ahead of outlook for at least $0.60 CER QIAstat-Dx, QuantiFERON and QIAcuity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback